Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Harvard University · Massachusetts General Hospital · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
617
total citations
- FWCI
- 58.03
- Percentile
- 100%
- References
- 59
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Atezolizumab
- Bevacizumab
- Medicine
- Angiogenesis
- Hepatocellular carcinoma
- Cancer research
- Sorafenib
- Vascular endothelial growth factor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.